3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
2
Ovarian Neoplasms
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Head and Neck Neoplasms
1
HER2-low Breast Cancer
1
Endometrial Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
tucatinib
1
pertuzumab
1
atezolizumab
1
Trastuzumab
1
Fulvestrant
1
Alpelisib
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
HER2-positive Metastatic Breast Cancer
×
RC48 antibody
×
1 year
×
Clear all
No trials found.